| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 37,800 | $30 | $1.2M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 12,470 | $30 | $324.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 21,610 | $10 | $216.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 460 | $90 | $39.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 570 | $50 | $26.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $80 | $21.7K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 230 | $20 | $4.9K |
| 73120 | X–rays of the extremities have been performed to assess injury, fracture, arthritis, bone spurs, tumors, or congenital abnormalities. Extremity X–rays include the hand, wrist, arm, foot, ankle, hip,… | 160 | $20 | $3.6K |
| 73620 | In this diagnostic procedure, the provider takes two X–ray views of a patient’s foot to assess an injury, fracture, arthritis, tumor, or congenital abnormality. | 160 | $20 | $3.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $110 | $2.3K |